BRPI0513622A - aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes - Google Patents
aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantesInfo
- Publication number
- BRPI0513622A BRPI0513622A BRPI0513622-9A BRPI0513622A BRPI0513622A BR PI0513622 A BRPI0513622 A BR PI0513622A BR PI0513622 A BRPI0513622 A BR PI0513622A BR PI0513622 A BRPI0513622 A BR PI0513622A
- Authority
- BR
- Brazil
- Prior art keywords
- surfactants
- seeds
- self
- lipid excipients
- emulsifying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
APLICAçãO DE COMBINAçõES AUTO-EMULSIFICANTES (SEEDS) DE EXCIPIENTES LIPìDICOS, DE SURFACTANTES; COMPOSIçãO FARMACêUTICA CONTENDO UM PRINCìPIO ATIVO E UMA COMBINAçãO AUTO-EMULSIFICANTE (SEEDS) DE EXCIPIENTES LIPìDICOS, DE SURFACTANTES; E PROCESSO PARA A PREPARAçãO DE COMBINAçõES AUTO-EMULSIFICANTES (SEEDS) DE EXCIPIENTES LIPìDICOS, DE SURFACTANTES, onde as formulações farmacêuticas inovadoras tornam possível melhorar a absorção intestinal de princípios ativos administrados oralmente, seu processo de preparação e a aplicação de excipientes lipídicos em combinação com um ou mais surfactantes e um ou mais co-surfactantes para a inibição de bombas de refluxo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408269A FR2873585B1 (fr) | 2004-07-27 | 2004-07-27 | Nouvelles formulations galeniques de principes actifs |
PCT/FR2005/001853 WO2006018501A1 (fr) | 2004-07-27 | 2005-07-20 | Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0513622A true BRPI0513622A (pt) | 2008-05-13 |
Family
ID=34951660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0513622-9A BRPI0513622A (pt) | 2004-07-27 | 2005-07-20 | aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes |
Country Status (18)
Country | Link |
---|---|
US (2) | US20080193519A1 (pt) |
EP (1) | EP1771154A1 (pt) |
JP (1) | JP2008508191A (pt) |
KR (1) | KR20070046819A (pt) |
CN (1) | CN101001608A (pt) |
AU (1) | AU2005273839A1 (pt) |
BR (1) | BRPI0513622A (pt) |
CA (1) | CA2579449A1 (pt) |
FR (1) | FR2873585B1 (pt) |
IL (1) | IL180714A0 (pt) |
MA (1) | MA28748B1 (pt) |
MX (1) | MX2007001141A (pt) |
NO (1) | NO20070354L (pt) |
NZ (1) | NZ552715A (pt) |
RU (1) | RU2381789C2 (pt) |
TW (1) | TW200616640A (pt) |
WO (1) | WO2006018501A1 (pt) |
ZA (1) | ZA200700553B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1867323A1 (en) * | 2006-06-13 | 2007-12-19 | Farmatron Ltd. | Pharmaceutical compositions with biological barriers permeation enhancing properties |
AU2008290536B2 (en) * | 2007-08-21 | 2012-02-09 | Basilea Pharmaceutica Ag | Antifungal composition |
WO2011047259A1 (en) | 2009-10-16 | 2011-04-21 | Glaxosmithkline Llc | Compositions |
JP2013209294A (ja) * | 2010-07-30 | 2013-10-10 | Meiji Seikaファルマ株式会社 | 液状医薬組成物 |
LT2782584T (lt) | 2011-11-23 | 2021-09-10 | Therapeuticsmd, Inc. | Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
KR101542364B1 (ko) * | 2014-10-31 | 2015-08-07 | 대화제약 주식회사 | 탁산을 포함하는 경구 투여용 약학 조성물 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
KR20210102936A (ko) * | 2018-12-10 | 2021-08-20 | 헤일로 사이언스 엘엘씨 | 안정적인 마취제 제제 및 관련 복용량 형태 |
CZ309587B6 (cs) * | 2021-01-22 | 2023-05-03 | Oncora S.R.O. | Mikroemulzní prekoncentrát s obsahem kladribinu a způsob jeho přípravy |
CN114246827B (zh) * | 2022-01-04 | 2023-04-11 | 中山大学 | 一种鱼油微乳制剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8916901D0 (en) * | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
FR2710535B1 (fr) * | 1993-09-30 | 1995-11-24 | Gattefosse Ets Sa | Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion. |
EP0933367A1 (en) * | 1997-12-19 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists |
SK10632000A3 (sk) * | 1998-01-23 | 2001-02-12 | Aventis Pharma Deutschland Gmbh | Sulfónamidové deriváty ako inhibítory resorpcie kostí a inhibítory bunkovej adhézie |
ATE327735T1 (de) * | 1998-04-01 | 2006-06-15 | Jagotec Ag | Taxan-mikroemulsionen |
WO2000003753A2 (en) * | 1998-07-14 | 2000-01-27 | Em Industries, Inc. | Microdisperse drug delivery systems |
GB0003685D0 (en) * | 2000-02-17 | 2000-04-05 | Univ Cardiff | Sensitisation of cellular material |
FR2818905A1 (fr) * | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
FR2827770B1 (fr) * | 2001-07-27 | 2005-08-19 | Gattefosse Ets Sa | Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal |
US20040092428A1 (en) * | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
WO2003095447A1 (en) * | 2002-05-14 | 2003-11-20 | Xenova Limited | Process for the preparation of a hydrate of an anthranilic acid derivative |
-
2004
- 2004-07-27 FR FR0408269A patent/FR2873585B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-20 NZ NZ552715A patent/NZ552715A/en not_active IP Right Cessation
- 2005-07-20 MX MX2007001141A patent/MX2007001141A/es not_active Application Discontinuation
- 2005-07-20 BR BRPI0513622-9A patent/BRPI0513622A/pt not_active IP Right Cessation
- 2005-07-20 JP JP2007521988A patent/JP2008508191A/ja active Pending
- 2005-07-20 CA CA002579449A patent/CA2579449A1/en not_active Abandoned
- 2005-07-20 WO PCT/FR2005/001853 patent/WO2006018501A1/fr active Application Filing
- 2005-07-20 EP EP05790808A patent/EP1771154A1/fr not_active Withdrawn
- 2005-07-20 AU AU2005273839A patent/AU2005273839A1/en not_active Abandoned
- 2005-07-20 CN CNA2005800268156A patent/CN101001608A/zh active Pending
- 2005-07-20 KR KR1020077001445A patent/KR20070046819A/ko not_active Application Discontinuation
- 2005-07-20 US US11/572,402 patent/US20080193519A1/en not_active Abandoned
- 2005-07-20 RU RU2007107199/15A patent/RU2381789C2/ru not_active IP Right Cessation
- 2005-07-26 TW TW094125195A patent/TW200616640A/zh unknown
-
2007
- 2007-01-15 IL IL180714A patent/IL180714A0/en unknown
- 2007-01-19 NO NO20070354A patent/NO20070354L/no not_active Application Discontinuation
- 2007-01-19 ZA ZA200700553A patent/ZA200700553B/en unknown
- 2007-01-23 MA MA29627A patent/MA28748B1/fr unknown
-
2010
- 2010-08-27 US US12/870,250 patent/US20110104268A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MA28748B1 (fr) | 2007-07-02 |
US20110104268A1 (en) | 2011-05-05 |
WO2006018501A8 (fr) | 2007-03-01 |
KR20070046819A (ko) | 2007-05-03 |
NO20070354L (no) | 2007-04-17 |
CA2579449A1 (en) | 2006-02-23 |
FR2873585A1 (fr) | 2006-02-03 |
TW200616640A (en) | 2006-06-01 |
ZA200700553B (en) | 2008-05-28 |
IL180714A0 (en) | 2007-06-03 |
US20080193519A1 (en) | 2008-08-14 |
AU2005273839A1 (en) | 2006-02-23 |
MX2007001141A (es) | 2007-04-19 |
NZ552715A (en) | 2010-12-24 |
RU2381789C2 (ru) | 2010-02-20 |
CN101001608A (zh) | 2007-07-18 |
FR2873585B1 (fr) | 2006-11-17 |
EP1771154A1 (fr) | 2007-04-11 |
RU2007107199A (ru) | 2008-09-10 |
WO2006018501A1 (fr) | 2006-02-23 |
JP2008508191A (ja) | 2008-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513622A (pt) | aplicação de combinações auto-emulsificantes (seeds) de excipientes lipìdicos, de surfactantes; composição farmacêutica contendo um princìpio ativo e uma combinação auto-emulsificante (seeds) de excipientes lipìdicos, de surfactantes; e processo para a preparação de combinações auto-emulsificantes (seeds) de excipientes lipìdios, de surfactantes | |
BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
AR048705A1 (es) | Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
EA200800360A1 (ru) | Формуляции с высоким содержанием лекарства и дозированные формы | |
BRPI0519280A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto | |
NO20082269L (no) | Nye piperaziner som antimalariamidler | |
ATE356612T1 (de) | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit | |
MY143549A (en) | Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases | |
DK1341524T3 (da) | Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel | |
NO20081038L (no) | Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering | |
FR2878161B1 (fr) | Forme medicamenteuse orale, solide et concue pour eviter le mesusage | |
CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
AR034813A1 (es) | Composiciones farmaceuticas y uso de las mismas | |
ECSP067074A (es) | Derivados de 4-fenil-pirimidina-2-carbonitrilo | |
BRPI0614197B8 (pt) | composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição | |
AR086491A1 (es) | Composicion farmaceutica que comprende fexofenadina | |
AR053333A1 (es) | Composiciones farmaceuticas orales y parenterales que contienen altas concentraciones de agentes solubilizantes aromaticos | |
EA200602199A1 (ru) | Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство | |
PT1208078E (pt) | Sais nao higroscopicos de substancias activas com actividades terapeuticas e/ou nutricionais e composicoes passiveis de serem administradas oralmente contendo os mesmos | |
BR0215352A (pt) | Composição farmacêutica que compreende um inibidor de alfa-glicosidase e um ácido 4-oxobutanóico, e seu uso para tratar diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |